Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PROVEPHARM SAS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 40
  • 0 comments

FDA approve DIHYDROERGOTAMINE MESYLATE

Comment Full text

WATSON LABS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 46
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 48
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 44
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

HERITAGE PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 43
  • 0 comments

FDA approve METOPROLOL TARTRATE

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 43
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 47
  • 0 comments

FDA approve PREGABALIN

Comment Full text

SANDOZ INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 35
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

ACTAVIS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 38
  • 0 comments

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 362
  • 363
  • 364
  • 365
  • 366
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216355)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137541)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin